… found that patients receiving the lower doses of apixaban, rivaroxaban, or dabigatran had
more … In this study, low-dose edoxaban significantly reduced the risk of stroke and SE without …

… DOACs (apixaban, rivaroxaban, dabigatran) vs warfarin, Cox … Loire Valley Non-valvular AF
Project and studied 8,962 patients (… of low dose DOACs in patients with a high risk of bleeding …

… of factor Xa (apixaban, edoxaban, and rivaroxaban) or of thrombin (dabigatran). RCTs have
… Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: do …

… of this study DOAC dose was stratified as “low” (dabigatran 75 … apixaban compared with
warfarin, which our results agreed with. We found rivaroxaban to significantly increase the risk of …

… in patients with non-valvular atrial fibrillation per labels/… fewer major bleeding events compared
to warfarin. However, head-to-… the levels of dabigatran, rivaroxaban and apixaban, while …

… atrial fibrillation (NVAF) is associated with an increased risk of … ) and other clinical tests (such
as blood pressure values) are not … In this study, we used an administrative claims database, …

… /min, dabigatran 150 mg and apixaban were associated with … bleeding whereas both doses
of dabigatran and rivaroxaban … versus warfarin in patients with non-valvular atrial fibrillation …

… in patients with atrial fibrillation (AF) at significant stroke risk. … bleeding (including intracranial
hemorrhage) than warfarin (2… could receive rivaroxaban, apixaban, or dabigatran (the …

… -AF (Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients) trial, … bleeding risk from
warfarin, rivaroxaban, and dabigatran compared with no anticoagulant agent or apixaban. A …

… Vitamin K antagonists (VKAs) such as warfarin had long … could receive either rivaroxaban,
apixaban, or dabigatran at the … %) DOAC patients received low-dose apixaban, appropriately …